The French drugmaker said fourth-quarter business net income fell 13.5 percent at constant exchange rates to 1.71 billion euros ($1.92 billion). Total sales dropped 1.6 percent to 9.28 billion.
Analysts polled by Reuters in partnership with Inquiry Financial had on average been expecting business net profit of 1.69 billion euros and net sales of 9.34 billion.